Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.94), $0.12 better than the analyst estimate of ($1.06). Revenue for the quarter came in at $22 thousand versus the consensus estimate of $802.64 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.